Last deal

$294K

Amount

Grant

Stage

31.05.2023

Date

3

all rounds

$13.49M

Total amount

date founded

Financing round

General

About Company
Zylö Therapeutics offers an innovative drug-delivery system.

Industry

Sector :

Subsector :

founded date

01.11.2017

Number of employees

Company Type

For Profit

Last funding type

Grant

IPO status

Private

Description

The South Carolina-based company, founded in 2017, has developed a topical delivery system that uses patented hydrogel-derived nanoparticles to deliver therapeutic agents in a sustained and controlled manner. The system, called Nanopods, encapsulates compounds to improve product performance and enhance drug delivery capabilities. The technology has the potential to treat a range of conditions, including lupus, hair loss, joint pain, and burns.
Contacts

Contact Email

Phone number

Social url

Similar Companies
1000
Aegis Therapeutics

Aegis Therapeutics

Aegis Therapeutics commercializes drug delivery and formulation technologies.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Pharmaceuticals, Health Care

Location

San Diego, CA, USA
Caliber Therapeutics

Caliber Therapeutics

Caliber Therapeutics develops stent-free drug delivery products for atherosclerotic diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

New Hope, PA 18938, USA

total rounds

1

total raised

$12M
Medallion Therapeutics

Medallion Therapeutics

Medallion Therapeutics delivers better therapies through innovative drug and biologics delivery solutions.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Valencia, Santa Clarita, CA, USA
AerovectRx

AerovectRx

AerovectRx is an aerosol therapeutic company that develops pulmonary drug delivery technologies for enterprises and individuals.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Atlanta, GA, USA

total rounds

5

total raised

$1.2M

Financials

Funding Rounds
8
3

Number of Funding Rounds

$13.49M

Money Raised

Their latest funding was raised on 31.05.2023. Their latest investor National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). Their latest round Grant

Date 
Funding Round 
Investors 
Money Raised 
Lead 

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIAMS is a research institute focused on arthritis, musculoskeletal, and skin diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care

count Of Investments

21

James Cordes

count Of Investments

1
SC Launch, Inc.

SC Launch, Inc.

SC Launch, Inc. is a non-profit that provides loans and investments to South Carolina-based companies.

Sector

Finance and Credit Services

Subsector

Consumer Lending

Keywords

Financial Services, Non-Profit

Location

Columbia, SC, USA

count Of Investments

35
Co-Investors
Investors
11
4

Number of lead investors

11

Number of investors

Investor 
Lead 
Round 
Partners 
No
Seed, Series A, Series B
Yes
Seed, Series A, Series B

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIAMS is a research institute focused on arthritis, musculoskeletal, and skin diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care

count Of Investments

21
New York Angels

New York Angels

New York Angels is a professional angel organization that finds, funds, and mentors early-stage companies.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital, Finance

Location

New York, NY, USA

count Of Investments

199

count Of Exists

42
VentureSouth

VentureSouth

VentureSouth is an early stage venture firm that operates angel groups and funds.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Financial Services, Finance

Location

Greenville, SC, USA

count Of Investments

142

count Of Exists

12

People

Founders
1
Scott R. Pancoast
Scott R. Pancoast

Scott R. Pancoast

Scott R. Pancoast, CEO (and Company Founder and Board Member): Scott Pancoast was CEO and board member of Lpath [NASDAQ:LPTN] from 2005 through 2014 and was Chairman of the company from 1999 through 2010. He evolved this start-up from incubation at San Diego State University to eventual public-company status and raised about $150 million, with more than $50 million coming from non-dilutive government grants and from partnership proceeds. He forged worldwide partnerships with Merck-Serono and Pfizer and attracted equity investments from J&J and Biogen Idec. As EVP of Western States Investment Group from 1994 until 2004, he invested in and managed a portfolio of startups ranging from Endonetics (sold to Medtronic) to Mpex (sold to Axcan) to DermTech (currently in revenue ramp). He has served on over a dozen boards, including three public ones. Mr. Pancoast holds a BA in economics summa cum laude from the University of Virginia and an MBA with honors from Harvard Business School.

current job

Zylö Therapeutics
Zylö Therapeutics

organization founded

1

Scott R. Pancoast

Employee Profiles
2
Michael Rabin

Michael Rabin

VP Business Development & Strategy

Scott R. Pancoast

Scott R. Pancoast

CEO

Activity

Recent News
1